Novakand Pharma AB (publ) (STO:NOVKAN)
0.103
-0.021 (-17.04%)
Mar 9, 2026, 4:56 PM CET
-93.20% (1Y)
| Market Cap | 15.08M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -47.23M |
| Shares Out | 121.19M |
| EPS (ttm) | -0.39 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 476,885 |
| Average Volume | 676,042 |
| Open | 0.115 |
| Previous Close | 0.124 |
| Day's Range | 0.102 - 0.130 |
| 52-Week Range | 0.075 - 2.250 |
| Beta | 0.92 |
| RSI | 43.96 |
| Earnings Date | Feb 20, 2026 |